Jacqueline French, M.D.
Jacqueline A. French, M.D., an internationally recognized leader in the medical treatment of epilepsy, is president of the American Epilepsy Society (AES). The AES is a 3,000-member Society, and the world's largest organization of epilepsy physicians and healthcare professionals dedicated to the prevention, treatment and cure of the disorder.
Dr. French is a professor in the Department of Neurology at NYU Langone Medical Center and director of translational research and clinical trials at the Comprehensive Epilepsy Center. She also is director of the Clinical Trials Consortium, an academic group that has performed a number of early phase clinical trials in epilepsy, and which has developed new methodologies for testing epilepsy medications. Her research is focused on development of new therapeutics fore epilepsy and on new guidance systems for clinical trials.
Dr. French has been active in creating medical practice guidelines for the American Academy of Neurology (AAN) and the International League Against Epilepsy (ILAE). She chaired an AAN/AES committee that produced two widely quoted guidelines on the use of new antiepileptic drugs.
Prior to her election as president, Dr. French had been the 1st vice president of the AES board. She is the 2005 recipient of the AES Service Award. She also serves as secretary of the American Society of Experimental Neurotherapeutics and head of the Scientific Advisory Board of the Epilepsy Therapy Project. Dr. French has als oserved as chair of the ILAE North American Regional Commission and The League's Commission on Therapeutic Strategies.
Dr. French trained in neurology at Mount Sinai Hospital, N.Y., and completed fellowship training in encephalography (EEG) and epilepsy at Mount Sinai Hospital and Yale University. She has authored over 150 articles and book chapters and edited three medical books, and lectures internationally on clinical trials and use of antiepileptic drugs.